Skip to main content
OpenTrials
Completed

NCT Number: NCT05834270

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostatic Neoplasms Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostate Disease Prostate Hypertrophy Prostate Obstruction Prostatic Diseases Prostatic Hyperplasia Urogenital Diseases Urogenital Neoplasms

Age range

50 year–80 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine

Shibīn al Kawm, Menofia, 342007, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age more than 50 years
  • moderate to severe lower urinary tract symptoms

Exclusion criteria

  • prostatic cancer
  • urethral stricture
  • prostate surgery
  • Neurogenic bladder

Treatment and study plan

Single dose tamsulosin 0.4mg

Drug

Single dose tamsulosin 0.4mg

Double dose tamsulosin 0.4mg

Drug

Double dose tamsulosin 0.4mg

Primary outcomes

  1. Change in the lower urinary tract symptoms

    Time frame: 3 months

    Assessed by the improvement in the internal prostatic symptoms score (IPSS)

Sponsors and collaborators

Lead sponsor

Menoufia University

Other

Registry information

Official study title

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 28, 2023
Registry last updated
Apr 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.